ANI Pharmaceuticals Inc. (ANIP)
NASDAQ: ANIP
· Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
ANI Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 211.37M | 197.12M | 190.57M | 148.33M | 138.04M | 137.43M | 131.65M | 131.83M | 116.55M | 106.79M | 94.23M | 83.82M | 73.86M | 64.48M | 60.93M | 52.06M | 48.63M | 54.52M |
Cost of Revenue | 97.9M | 73.04M | 80.28M | 63.08M | 72.39M | 63.84M | 68.61M | 48.1M | 42.28M | 37.71M | 36.33M | 32.89M | 35.29M | 34.27M | 33.9M | 24.41M | 22.31M | 19.98M |
Gross Profit | 113.47M | 124.08M | 110.29M | 85.26M | 65.64M | 73.59M | 63.04M | 83.73M | 74.26M | 69.08M | 57.91M | 50.93M | 38.56M | 30.21M | 27.03M | 27.65M | 26.31M | 34.54M |
Operating Income | 13.89M | 26.19M | -4.38M | -20.52M | 5.17M | 15.05M | 6.73M | 17.95M | 12.4M | 9.89M | 1.82M | -941K | -10.56M | -19.2M | -23.72M | -3.56M | -15.55M | 3.04M |
Interest Income | 2.78M | 2.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 10.53M | 19.99M | -13.76M | -31.5M | -2.29M | 25.34M | 947K | 11.51M | 5.25M | 2.17M | -5.73M | -12.22M | -18.82M | -25.9M | -30.85M | -7.13M | -18.15M | 76K |
Net Income | 7.73M | 15.68M | -10.28M | -24.17M | -2.29M | 18.21M | 1.16M | 9.94M | 6.25M | 1.44M | -4.24M | -8.6M | -14.92M | -20.13M | -24.14M | -4.45M | -14.11M | 81K |
Selling & General & Admin | 81.77M | 76.53M | 69.72M | 79.08M | 52.82M | 48.02M | 44.46M | 42.01M | 38.76M | 36.47M | 33.19M | 30.08M | 31.96M | 28.82M | 30.71M | 17.18M | 18.82M | 17.59M |
Research & Development | 16.54M | 10.56M | 16.65M | 10.13M | 7.3M | 10.51M | 9.87M | 11.12M | 7.37M | 5.92M | 5.22M | 7.66M | 4.17M | 5.27M | 3.14M | 2.46M | 2.81M | 2.97M |
Other Expenses | n/a | 10.8M | 28.31M | 16.57M | n/a | n/a | n/a | 12.65M | -53K | 14.7M | 17.68M | 14.17M | 13.76M | -89K | -2.69M | -1.07M | -67K | -515K |
Operating Expenses | 98.31M | 97.89M | 114.67M | 105.78M | 60.12M | 58.53M | 54.33M | 65.78M | 60.82M | 57.09M | 56.09M | 51.91M | 49.89M | 48.65M | 47.53M | 31.21M | 33.46M | 31.49M |
Interest Expense | 8.22M | 8.11M | 6.01M | 2.33M | 4.66M | 4.6M | 5.75M | 6.4M | 7.1M | 7.7M | 7.51M | 7.26M | 6.67M | 6.61M | 4.44M | 2.5M | 2.53M | 2.45M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 196.2M | 170.93M | 194.95M | 168.85M | 132.51M | 122.38M | 124.93M | 113.88M | 103.11M | 94.8M | 92.41M | 84.8M | 85.18M | 82.92M | 81.43M | 55.62M | 55.78M | 51.48M |
Income Tax Expense | 1.98M | 4.31M | -3.49M | -7.33M | n/a | 7.13M | -208K | 1.57M | -996K | 726K | -1.49M | -3.62M | -3.9M | -5.77M | -6.72M | -2.68M | -4.04M | -10K |
Shares Outstanding (Basic) | 19.83M | 19.61M | 19.45M | 19.4M | 19.32M | 19.1M | 19M | 18.88M | 17.69M | 16.39M | 16.32M | 16.3M | 16.27M | 16.14M | 14.17M | 12.02M | 12.06M | 12M |
Shares Outstanding (Diluted) | 20.31M | 20.05M | 19.45M | 19.4M | 19.32M | 19.42M | 19.22M | 19.13M | 17.86M | 16.53M | 16.32M | 16.3M | 16.27M | 16.14M | 14.19M | 12.11M | 12.09M | 12.02M |
EPS (Basic) | 0.37 | 0.70 | -0.55 | -1.27 | -0.14 | 0.84 | 0.04 | 0.50 | 0.33 | 0.06 | -0.28 | -0.53 | -0.92 | -1.25 | -1.7 | -0.37 | -1.17 | 0.01 |
EPS (Diluted) | 0.36 | 0.69 | -0.55 | -1.27 | -0.14 | 0.83 | 0.04 | 0.50 | 0.33 | 0.06 | -0.28 | -0.53 | -0.92 | -1.25 | -1.7 | -0.37 | -1.17 | 0.01 |
EBITDA | 42.03M | 50.98M | 14.85M | -13.42M | 23.73M | 29.74M | 23.91M | 30.6M | 26.5M | 26.69M | 17.35M | 9.99M | 1.02M | -5.73M | -13.83M | 7.78M | -5.5M | 12.23M |
EBIT | 18.75M | 28.09M | -7.75M | -29.17M | 2.37M | 15.05M | 7.29M | 18.51M | 11.75M | 9.86M | 1.78M | -4.96M | -12.15M | -19.28M | -27.51M | -4.63M | -15.62M | 2.53M |
Depreciation & Amortization | 23.28M | 22.89M | 22.6M | 15.75M | 14.7M | 14.69M | 15.19M | 15.21M | 14.75M | 14.7M | 15.57M | 15.35M | 14.17M | 14.56M | 13.68M | 11.35M | 11.32M | 10.9M |